Learn More
Our singular purpose
Opus is dedicated to advancing lipid nanoparticle delivery, ultimately unlocking the true potential of genetic medicines across a broad range of therapeutic areas.
Our platform
Superior LNP Delivery Platform
- 01
Opus Biosciences aims to advance a proprietary lipid nanoparticle delivery platform encompassing a novel class of LNPs, enabling enhanced delivery of genetic medicine payloads to a wider range of organs, tissues, and cells.
- 02
Our platform is designed to overcome the limitations of different delivery vectors including LNP formulations, such as safety, immunogenicity, and payload constraints to different targets.
- 03
By addressing key challenges in drug delivery, including toxicity, re-dosing, transfection, efficiency, precision, cost, and development time, Opus Biosciences is committed to advancing therapeutic delivery outcomes for the pharmaceutical industry.
Our story
Driving Innovation In Genetic Medicine Delivery
Opus was founded by the Murthy Lab at the Innovative Genomics Institute. Our team of scientists specializes in formulating innovative drug delivery solutions, aiming to leave a mark in the realm of genetic medicine.
